pros and cons of glp-1 agonist What should you do when a patient doesn't respond to a GLP-1? You've titrated the dose. You've optimized lifestyle support. They're adherent, motivated—and still, there is no expected weight loss. Before assuming glp 1 used for weight
Description
Key trials demonstrate: SUSTAIN-1 : HbA1c reduction ~1.45-1.55% with modest weight loss (~3.734.53 kg )
10.1056/NEJMoa022464 3 BeaversK
The success of these medicines has spurred development of next-generation GLP-1-based drugs, promising greater weight loss, improved tolerability and additional options for the route and frequency of dosing
Download it once and read it on your Kindle device, PC, phones or tablets
*Correspondence: Jonathan D
